Sutro Biopharma

Sutro Biopharma: Clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs). Sutro has two wholly owned ADCs in the clinic—STRO-002, a folate receptor alpha (FolRα)-targeting ADC, in clinical studies for ovarian and endometrial cancers; and STRO-001, a CD74-targeting ADC, in clinical studies for B-cell malignancies. STRO-003, an optimally designed ROR1-targeting ADC, is anticipated to be the next proprietary product candidate to move into clinical studies. Sutro also has high value collaborations with BMS (BCMA ADC), Merck (cytokine derivatives), EMD Serono (MUC1-EGFR bispecific ADC), and Astellas (immunostimulatory antibody-drug conjugates or iADCs).
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Autoimmune, Infectious Disease, Oncology
Public, USA
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Platform Technology
111 Oyster Point Blvd
South San Francisco, CA 94080
United States

Company Participants at Solebury Trout 1x1 Management Access Event 2022

  • Bill Newell, Chief Executive Officer

Top 10 Holders of Sutro Biopharma, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Suvretta Capital Management LLC 9.68 5,565,099 29.05 13F 12/31/22
BVF, Inc. 5.83 3,347,946 17.48 13F 12/31/22
Rubric Capital Management LP 5.59 3,211,872 16.77 13F 12/31/22
Franklin Advisers, Inc. 4.90 2,815,806 14.70 13F 12/31/22
The Vanguard Group, Inc. 4.57 2,629,396 13.73 Funds 2/28/23
Vanguard Group, Inc. (Subfiler) 4.52 2,595,535 13.55 13F 12/31/22
BlackRock Fund Advisors 4.17 2,394,689 12.50 13F 12/31/22
Holocene Advisors, LP 4.03 2,313,542 12.08 13F 12/31/22
Candriam Belgium SA 3.58 1,960,738 10.24 Funds 11/30/22
Baillie Gifford & Co. 3.25 1,868,615 9.75 13F 12/31/22
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.